Simple noninvasive measurement of skin autofluorescence

Annals of the New York Academy of Sciences

Volumn 1043, Issue , 2005, Pages 290-298

  Meerwaldt, Robbert ^a   Links, Thera ^a   Graaff, Reindert ^b   Thorpe, Suzannne R ^c   Baynes, John W ^c   Hartog, Jasper ^a   Gans, Reinold ^a   Smit, Andries ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Advanced glycation end products; Autofluorescence; Complications; Diabetes; Noninvasive

Indexed keywords

ADVANCED GLYCATION END PRODUCT; COLLAGEN; FLUORESCEIN SODIUM; HEMOGLOBIN A1C; HYDROXYPROLINE; N EPSILON (CARBOXYETHYL)LYSINE; N EPSILON (CARBOXYMETHYL)LYSINE; PENTOSIDINE; UNCLASSIFIED DRUG;

AUTOFLUORESCENCE; BIOACCUMULATION; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; KIDNEY FAILURE; KIDNEY FUNCTION; OXIDATIVE STRESS; PATHOGENESIS; QUANTITATIVE ANALYSIS; SKIN; SKIN BIOPSY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 23744467298     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1333.036     Document Type: Conference Paper

References (29)

1. ε-(carboxymethyl) lysine in human tissues in diabetes and aging. J. Clin. Invest. 9: 457-468.
2. STITT, A.W., C. HE, S. FRIEDMAN, et al. 1997. Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol. Med. 3: 617-627.
3. MIYATA, T., Y. WADA, Z. CAI, et al. 1997. Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. Kidney Int. 51: 1170-1181.
4. SMITH, M.A., S. TANEDA, P.L. RICHEY, et al. 1994. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA 91: 5710-5714.
5. MONNIER, V.M., V. VISHWANATH, K.E. FRANK, et al. 1986. Relation between complications of type 1 diabetes mellitus and collagen-linked fluorescence. N. Engl. J. Med. 314: 403-408.
6. BAYNES, J.W. & S.R. THORPE. 1999. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 48:1-9.
7. THE DCCT RESEARCH GROUP. 1993. The effect of intensive diabetes treatment on the development and progression of long-term complications in insulin-dependent diabetes: the Diabetes Control and Complications Trial. N. Engl. J. Med. 329: 977-986.
8. MONNIER, V.M., O. BAUTISTA, D. KENNY, et al. 1999. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes. Diabetes 48: 870-880.
9. NISHIKAWA, T., D. EDELSTEIN, X.L. DU, et al. 2000. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790.
10. THORNALLEY, P.J. 1998. Cell activation by glycated proteins, AGE receptors, receptor recognition factors and functional classification of AGE. Cell. Mol. Biol. 44: 1013-1023.
11. BEISSWENGER, P.J., Z. MAKITA, T.J. CURPHEY, et al. 1995. Formation of immunochemical advanced glycosylation end products precede and correlate with early manifestations of renal and retinal disease in diabetes. Diabetes 44: 824-829.
12. MAKITA, Z., S. RADOFF, E.J. RAYFIELD, et al. 1991. Advanced glycosylation end products in patients with diabetic nephropathy. N. Engl. J. Med. 325: 836-842.
13. CHIARELLI, F., M. DE MARTINO, A. MEZZETTI, et al. 1999. Advanced glycation end products in children and adolescents with diabetes: relation to glycemic control and early microvascular complications. J. Pediatr. 134: 486-491.
14. NILSSON, B.O. 1999. Biological effects of aminoguanidine: an update. Inflamm. Res. 48: 509-515.
15. WOLFFENBUTTEL, B.H., C.M. BOULANGER, F.R. CRIJNS, et al. 1998. Breakers of advanced glycation end products restore large artery properties in experimental diabetes. Proc. Natl. Acad. Sci. USA 95: 4630-4634.
16. SOULIS-LIPAROTA, T., M. COOPER, D. PAPAZOGLOU, et al. 1991. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozin-induced diabetic rats. Diabetes 40: 1328-1335.
17. HRICIK, D.E., Y.C. WU, A. SCHULAK, et al. 1996. Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation. Clin. Transplant. 10: 568-573.
18. DORRIAN, C.A., S. CATHCART, J. CLAUSEN, et al. 1998. Factors in human serum interfere with the measurement of advanced glycation endproducts. Cell. Mol. Biol. 44: 1069-1079.
19. KOEFOED THEIL, P., T. HANSEN, M. LARSEN, et al. 1996. Lens autofluorescence is increased in newly diagnosed patients with NIDDM. Diabetologia 39: 1524-1527.
20. MOTA, M.C., A.M. MORGADO, A. MATOS, et al. 1999. Evaluation of a non-invasive fluorescence technique as a marker for diabetic lenses in vivo. Graefes Arch. Clin. Exp. Ophthalmol. 237: 187-192.
21. SATO, E., F. MORI, S. IGARASHI, et al. 2001. Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. Diabetes Care 24: 479-482.
22. VAN DEN BERG, T.J.T.P. 1993. Quantal and visual efficiency of fluorescence in the lens of the human eye. Invest. Ophthalmol. Vis. Sci. 34: 3566-3573.
23. GRAY, J.R., M.A. MOSIER & B.M. ISHIMOTO. 1985. Optimized protocol for Fluorotron Master. Graefes Arch. Clin. Exp. Ophthalmol. 222: 225-229.
24. VAN BEST, J.A., J.L. VAN DELFT & J.E. KEUNEN. 1998. Long term follow-up of lenticular autofluorescence and transmittance in healthy volunteers. Exp. Eye Res. 66: 117-123.
25. JAGER, J., P.H.N. OOMEN, W.J. SLUITER, et al. 1997. Improved reproducibility of the "large-window" method of assessing transcapillary and interstitial fluorescein diffusion in the skin in healthy subjects and in subjects with insulin-dependent diabetes mellitus. Int. J. Microcirc. Clin. Exp. 17: 150-158.
26. MEERWALDT, R., R. GRAAFF, P.H. OOMEN, et al. 2004. Simple non-invasive assessment of advanced glycation endproduct accumulation. Diabetologia 47: 1324-1330.
27. MEERWALDT, R., A.J. SMIT, G.J. NAVIS, et al. 2000. Increased skin autofluorescence in diabetes mellitus and renal failure. Diabetologia 44(Suppl.): A1046.
28. NICOLL, I.D., A.W. STITT, J.E. MOORE, et al. 1998. Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers. Mol. Med. 4: 594-601.
29. KOSCHINSKY, T., C.J. HE, T. MITSUHASHI, et al. 1997. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc. Natl. Acad. Sci. USA 94: 6474-6479.